Jouliana Sadek Joins the Kyowa Kirin North America Team as Associate Director, Medical Value Outcomes Liaison
Jouliana Sadek, Associate Director, Medical Value Outcomes Liaison at Kyowa Kirin North America, shared a post on LinkedIn:
“After an incredible journey as a Senior Medical Science Liaison in the biosimilars space—supporting multiple product launches and collaborating with brilliant minds across Immunology and Hematology/Oncology—I’m excited to begin a new chapter.
I’m proud to join the Kyowa Kirin North America team as Associate Director, Medical Value Outcomes Liaison, where every day we strive to make a hashtag#profoundimpact. In this role, I’ll serve as the medical scientific lead for population-based healthcare decision makers, advancing evidence-based care and strategic partnerships through our oncology collaboration with KURA Oncology.
My commitment to enhancing patient care remains at the heart of everything I do. From identifying evidence gaps to facilitating research and education, I’m energized by the opportunity to shape meaningful scientific collaborations and drive innovation that truly serves patients and providers.
Grateful for my time at Fresenius Kabi, where I grew as a scientific leader, honed strategic engagement skills, and proudly served as a Cultural Ambassador. Thank you to the amazing mentors, colleagues, and collaborators who made the journey so rewarding.”
More posts on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023